ALPHA TRIBE

Indrayani Biotech LtdBoard Meeting, 26-02-2026: Board Meeting

26-02-2026 | 09:26 pm

Indrayani Biotech's board approved Q3 FY26 financial results. Consolidated Revenue was ₹35.01 Cr with ₹0.12 Cr profit. Mr. Kunisetty Venkateswara Rao is the new CFO. Company secured ₹5 Cr credit and is expediting its Rights Issue.

No comments yet. Be the first to comment!

All announcements from Indrayani Biotech Ltd